AJP - Endo Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 276: E365-E375, 1999;
0193-1849/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, J.
Right arrow Articles by Turner, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, J.
Right arrow Articles by Turner, R.
Vol. 276, Issue 2, E365-E375, February 1999

Discrimination, adjusted correlation, and equivalence of imprecise tests: application to glucose tolerance

Jonathan Levy, Richard Morris, Margaret Hammersley, and Robert Turner

Diabetes Research Laboratories, Department of Clinical Medicine, Oxford University, Oxford OX2 6HE, United Kingdom

Comparison studies between physiological tests are often unsatisfactory for assessing their ability to distinguish between subjects. We recommend a simple but comprehensive protocol, using duplicate testing, that compares tests using 1) the discriminant ratio (DR) between the underlying between- and within-subject SDs, 2) correlation coefficients adjusted for attenuation due to test imprecision, and 3) unbiased estimation of the underlying linear relationship between test results. The following five alternative methods for assessing glucose tolerance were compared: fasting plasma glucose (FPG) as a single sample or as the mean of three 5-min samples (FPG3); the 1- and 2-h glucose during a low-dose intravenous glucose infusion (CIG); and the 2-h plasma glucose from a 75-g oral glucose tolerance test (OGTT). All tests had similar DRs ranging from 2.6 to 4.2. The adjusted correlation between FPG and CIG tests approached unity, and those between OGTT and other tests were ~0.9, showing that FPG3 provides similar information to the OGTT. FPG concentrations of 6.0 and 7.1 were found equivalent to the 1985 World Health Organization OGTT thresholds for impaired glucose tolerance and diabetes (7.8 and 11.1 mmol/l).

plasma glucose; precision


This article has been cited by other articles:


Home page
Diabetes CareHome page
M. Buysschaert, I. Joudi, P. Wallemacq, and M. P. Hermans
Performance of Serum Cystatin-C Versus Serum Creatinine in Subjects With Type 1 Diabetes
Diabetes Care, April 1, 2003; 26(4): 1320 - 1320.
[Full Text] [PDF]


Home page
Diabetes CareHome page
G.D. Tan, A.V. Lewis, T.J. James, P. Altmann, R.P. Taylor, and J.C. Levy
Clinical Usefulness of Cystatin C for the Estimation of Glomerular Filtration Rate in Type 1 Diabetes: Reproducibility and accuracy compared with standard measures and iohexol clearance
Diabetes Care, November 1, 2002; 25(11): 2004 - 2009.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online